![Richard F. Labaudinière](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Richard F. Labaudinière
Président chez PreciThera, Inc.
Provenance du réseau au premier degré de Richard F. Labaudinière
Entité | Type d'entité | Industrie | |
---|---|---|---|
PreciThera, Inc.
![]() PreciThera, Inc. Pharmaceuticals: MajorHealth Technology Precithera, Inc. engages in drug development business. The firm focuses on the design and the development of biological agents for the treatment of orphan diseases. The company was founded by Philippe Crine and Susan Schiavi on May 26, 2016 and is headquartered in Outremont, Canada.
4
| Holding Company | Pharmaceuticals: Major | 4 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Richard F. Labaudinière via son réseau personnel
Société | Secteur | Personnes liées | Poste principal |
---|---|---|---|
University of Montréal | College/University | Doctorate Degree Graduate Degree Doctorate Degree | |
Enobia Pharma, Inc.
![]() Enobia Pharma, Inc. Pharmaceuticals: MajorHealth Technology Enobia Pharma, Inc. develops therapies to treat patients with ultra-rare and life-threatening genetic metabolic bone disorders. Its lead product candidate, asfotase alfa or ENB-0040, is a treatment for hypophosphatasia—a life-threatening disease that can cause skeletal deformity, severe muscle weakness and progressive damage to vital organs. The company was founded in 1997 and is headquartered in Montreal, Canada. | Pharmaceuticals: Major | Founder | |
Institut de recherches cliniques de Montréal
![]() Institut de recherches cliniques de Montréal Miscellaneous Commercial ServicesCommercial Services Institut de recherches cliniques de Montréal operates as an independent non-profit research institution focusing on biomedical research. The firm excels in basic research of economic development in the fields of pharmaceuticals, biotechnology and health services. The company was founded in 1967 and is headquartered in Montr?al, Canada. | Miscellaneous Commercial Services | Director/Board Member | |
Gemin X Pharmaceuticals US, Inc.
![]() Gemin X Pharmaceuticals US, Inc. BiotechnologyHealth Technology Gemin X Pharmaceuticals US Inc. is engaged in the development of cancer therapeutics. It offers mimetic and telomere capping programs, as well as screening, medicinal chemistry, and preclinical development services. The company was founded by Gordon C. Shore in 1998 and is headquartered in Malvern, PA. | Biotechnology | Chief Tech/Sci/R&D Officer | |
Novartis Pharmaceuticals Corp.
![]() Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal | |
McGill University | College/University | Doctorate Degree | |
Sanderling Management CO LLC
![]() Sanderling Management CO LLC Investment ManagersFinance Sanderling Management CO LLC (Sanderling Ventures) is a venture capital firm founded in 1979 by Robert G. McNeil. The firm is headquartered in San Mateo, California. | Investment Managers | Private Equity Investor | |
DalCor Pharmaceuticals Canada, Inc.
![]() DalCor Pharmaceuticals Canada, Inc. Pharmaceuticals: MajorHealth Technology DalCor Pharmaceuticals Canada, Inc. develops precision treatments for cardiovascular diseases. It offers dalcetrapib, a cholesterol ester transfer protein (CETP) inhibitor, as a potential targeted treatment to address the residual cardiovascular risk in patients carrying a specific ADCY9 genetic profile. The company was founded by Andr? Roger Desmarais and is headquartered in Montreal, Canada. | Pharmaceuticals: Major | Director/Board Member | |
Université du Québec à Montréal | College/University | Graduate Degree | |
adMare Bioinnovations
![]() adMare Bioinnovations adMare Bioinnovations engages in the provision of research for its academic and biotech partners. The company was founded in 2011 and is headquartered in Vancouver, Canada. | Director/Board Member | ||
CTI Capital, Inc.
![]() CTI Capital, Inc. Investment ManagersFinance CTI Capital, Inc. is a Venture Capital firm, a subsidiary of CTI Capital Groupe, Inc. founded in 1987. CTI Capital, Inc. is headquartered in Montréal. | Investment Managers | Private Equity Investor | |
Find Therapeutics
![]() Find Therapeutics BiotechnologyHealth Technology Find Therapeutics develops therapeutics for inflammatory and fibrotic disease. The company is headquartered in Saint-Laurent, Canada. | Biotechnology | President |
Statistiques
Internationale
Canada | 12 |
Etats-Unis | 4 |
Sectorielle
Health Technology | 7 |
Consumer Services | 4 |
Finance | 4 |
Commercial Services | 2 |
Opérationnelle
Director/Board Member | 9 |
Doctorate Degree | 3 |
Graduate Degree | 3 |
Chief Tech/Sci/R&D Officer | 2 |
Founder | 2 |
Relations les plus connectées
- Bourse
- Insiders
- Richard F. Labaudinière
- Connexions Sociétés